Cell Isolation Market Research Report - Forecast till 2027

Cell Isolation Market: Information By Product (Consumables and Instruments), Cell Type (Human Cells and Animal Cells), By Technique (Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation and Filtration-Based Cell Isolation), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics and Therapeutics), By End User (Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Cell Banks and Hospitals and Diagnostic Laboratories) - Forecast till 2027

ID: MRFR/LS/4734-CR | July 2019 | Region: Global | 157 pages

Cell Isolation Market Overview:


According to MRFR, the Cell Isolation Market is poised to mature at a CAGR of 17.1% and acquire a value of USD 10.56 Billion during the review period of 2018 to 2023. The need for cell isolation is expected to rise with the rising prevalence of cancer and infectious diseases. 


COVID-19 Analysis


COVID-19 is an infectious disease caused by a new coronavirus that was most recently discovered. COVID-19 moved from a localised crisis to a global pandemic in only a few weeks, mostly unknown until the outbreak began in Wuhan (China) in December 2019. Although the COVID-19 pandemic tends to transform the development of multiple sectors, the immediate effect of the epidemic varies. While a decline in demand has been reported by a few sectors, many others will continue to remain unscathed and display exciting prospects for growth.


Market Dynamics


Drivers


Growing cancer prevalence, government support for cell-based research, and technical advances are key factors for the development of the demand for cell isolation. Cell isolation market development is driven by the increasing number of cancer and infectious disease patients, expanded federal support for cell-based research, a growing emphasis on precision medicine, and developments in technology. Another big factor driving the growth of the cell isolation market is the growing need for customised medicine. Personalized care is a form of psychiatric therapy in which a particular patient is tailored for the procedure. In personalised medicine, cell separation methods may be used for early diagnosis of illness, allocation of suitable medication and assessment of therapeutic prognosis.


Opportunities


Increasing R&D Activities In The Pharmaceutical Sector Creates Growth Avenues for Key Players


To explain their biology and create novel cell therapies and other cell-based approaches, researchers use isolated cells. Due to its significance, numerous government bodies around the globe have expanded their funding for the growth of such research activities. In the past two years, support has risen dramatically for the development of cell therapies. In exchange, this increases the cell isolation market for supplies, media, reagents, and accessories used in research into cell isolation. The use of many advanced equipment and methodologies is projected to grow in developing economies with the goal of rising competitiveness due to the increasing R&D activities in the pharmaceutical and biotechnology industries.


Restraints


High Cost Of Cell Isolation Systems To Impede Market Growth


On the other hand, during the projected timeframe, the high cost of cell isolation systems, complex cell behavioural features, and ethical concerns related to embryonic stem cell isolation are likely to hamper market development. The cost of study in cell biology is high because of the need to uphold high quality standards and comply with the requirements set out by regulatory authorities. Furthermore, the cell-based research success rate is very limited, and most cell therapy trials have a low success rate. Owing to financial limitations, it is impossible for numerous organisations and small-scale enterprises to buy luxury goods. As a consequence, in these countries, the use of automated kits and instruments is limited. This is one of the key reasons limiting the development of the market for cell isolation equipment.


Cell Isolation Market Segmental Analysis:


Global Cell Isolation Market is segmented on the basis of Product, Cell Type, Technique, Application, End-User, and Region. 


By Product


With a market valuation of USD 2343.3 million in 2017, consumables account for the largest share of the overall market and are forecast to reach a CAGR of 17.5 percent over the evaluation period.


By Cell Type


Owing to the rising cancer incidence that has prompted a heavy emphasis on cancer research and human stem cell therapy, the human cell type segment has the largest share of the overall market. At a CAGR of 17.4 percent during the forecast period, the human cell type segment is expected to show good growth.


By Technique


At present, owing to the widespread use of this technique in university and research labs, the largest section is centrifugation-based cell isolation. Its widespread use, as opposed to other segments, is due to its affordability. Over the analysis period, centrifugation-based cell isolation is predicted to display a CAGR of 17.3 percent.


By Application


Due to the growing interest in biologics, investment in biotechnology, the prevalence of chronic diseases and the increasing need for highly efficient therapeutic solutions that stand up to the resistance of drug molecules, the biomolecules isolation segment accounts for the most important share of the overall market. In the meantime, the cancer research segment is increasingly rising and a CAGR of 17.6 percent is projected to be achieved during the forecast period due to the increasing recognition of cancer and the participation of different government health agencies in the funding of cancer research.


By End-User


Owing to the usage of cell-based assays in the diagnosis of different diseases, the growing emphasis on biotechnology in the face of increasing cancer incidences and the increasing market for monoclonal antibodies & FABs as cancer therapies, biotechnology and biopharmaceutical companies are expected to report a CAGR of 17.7 percent during the study period.


Cell Isolation Market Regional Analysis:


The geographical overview of the global market has been conducted in four major regions, including the Asia Pacific, North America, Europe, and the rest of the world.


North America to Witness the Highest Growth


The Americas is expected to dominate the cell isolation market. The increase in the patient pool for chronic diseases, government funding for cancer research and presence of strong market players like Thermo Fisher Scientific drive the market growth in this regionThe regional market is driven by the growing need for viable care alternatives. In addition, the country is technologically innovative and there are substantially developed healthcare industries in emerging countries in the region that are at the forefront of cutting-edge science and technology. Driven by the U.S., America currently accounts for the highest share of the overall market.


Growing Presence of Major Players to Lead APAC Market


Meanwhile, during the evaluation period, Asia Pacific is forecast to rise at a robust CAGR of 17.7 percent. Asia Pacific is projected to see rapid growth in the demand for cell isolation due to rising cancer incidence and increased spending on health. Compared to other countries, the emergence of a wide demographic with a substantial customer base and the current reforms launched by the government in an attempt to change the healthcare system are projected to drive the industry..


Competitive Landscape



  • Beckman Coulter (U.S.)

  • Becton, Dickinson and Company (U.S.)

  • GE Healthcare (U.K.)

  • Merck KGaA (U.S.)

  • Miltenyi Biotec (Germany)

  • pluriSelect (Germany)

  • STEMCELL Technologies Inc. (Canada)

  • Terumo BCT (U.S.)

  • Thermo Fisher Scientific, Inc. (U.S.)


Recent Development


December 2020: Applied Cells, Inc. today revealed that the organisation has launched its Early Access Program MARS Bar System, a groundbreaking fully integrated high-capacity closed system for cell processing.


Report Overview


By Product



  • Consumables

  • Instruments


By Cell Type



  • Human Cells

  • Animal Cells


By Technique



  • Centrifugation-Based Cell Isolation

  • Surface Marker-Based Cell Isolation

  • Filtration-Based Cell Isolation


By Application



  • Biomolecule Isolation

  • Cancer Research

  • Stem Cell Research

  • Tissue Regeneration

  • In Vitro Diagnostics

  • Therapeutics


By End-User



  • Research Laboratories and Institutes

  • Biotechnology and Biopharmaceutical Companies

  • Cell Banks

  • Hospitals and Diagnostic Laboratories



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 10.56 Billion
  CAGR   2018-2023: 17.1%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Cell Type, Technique, Application, End-User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Beckman Coulter (U.S.), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), Merck KGaA (U.S.), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (U.S.), Thermo Fisher Scientific, Inc. (U.S.)
  Key Market Opportunities

  • Growing Stem Cell Research
  • Application Of Cell Isolation In Microfluidics
  •   Key Market Drivers

  • Rising Government Funding For Cell-Based Research
  • Increasing Prevalence Of Cancer And Infectious Diseases
  • Growing Technological Advancements In Cell Isolation Devices
  • Growing Demand For Personalized Medicine


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The cell isolation market valuation would be USD 10,567.4 million by 2023.

    The projected CAGR would be 17.1% for the forecast period.

    The end users are biotechnology & biopharmaceutical companies, cell banks, research laboratories & institutes, and hospitals & diagnostic laboratories.

    The applications involved in the market are cancer research, biomolecule isolation, tissue regeneration, in-vitro diagnostics, stem cell research, and therapeutics.

    The cell isolation market includes human and animal cells.

    Global Cell Isolation Market: Competitive Landscape


    The global cell isolation market is a huge market with a number of big market players operating in various regions across the world. These players have come up with innovative products that are being used for various applications such as cancer research, stem cell research, and many others. Some of the major players include Thermo Fisher Scientific Inc., GE Healthcare, Becton, Dickinson and Company, Beckman Coulter, Merck KGaA, STEMCELL Technologies, Miltenyi Biotec, TERUMO CORPORATION, Bio-Rad Laboratories Inc, and F. Hoffmann-La Roche AG. Apart from these, there is a large number of companies involved in the development of new products.


    The global cell isolation market is currently dominated by Thermo Fisher Scientific Inc. with 11.8% of the total market share. Thermo Fisher Scientific with its technically magnificent products and skilled workforce is assisting its customers to accelerate life science research as well as to get better outcomes in challenging clinical research fields. Through their premier brands Thermo Scientific, Invitrogen, Fisher Scientific Applied Biosystems, and Unity Lab Services cater to several products such as analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others.


    GE Healthcare has the second largest market share in the global cell isolation market. GE Healthcare held 10.5% of the total market in 2017. The company was founded in 2004. GE Healthcare is a unit of General Electric Company.GE healthcare is expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions. It helps its customers to deliver better care and facilities around the world at low cost.


    It collaborates with human services pioneers, endeavoring to influence the worldwide arrangement change that is important to actualize an effective move toward practical medicinal service frameworks.


    GE Healthcare has generated massive revenues from the sales of healthcare. Besides these two, Becton, Dickinson and Company, Beckman Coulter, and Merck KGaA have secured third, fourth, and fifth positions with 9.6%, 7.9%, and 6.2% respectively of the market share.